Your browser doesn't support javascript.
loading
miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma.
Khella, Heba W Z; Butz, Henriett; Ding, Qiang; Rotondo, Fabio; Evans, Kenneth R; Kupchak, Peter; Dharsee, Moyez; Latif, Ashraf; Pasic, Maria D; Lianidou, Evi; Bjarnason, Georg A; Yousef, George M.
Affiliation
  • Khella HWZ; Department of Laboratory Medicine, and the Keenan Research Centre for Biomedical Science at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
  • Butz H; Department of Laboratory Medicine, and the Keenan Research Centre for Biomedical Science at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Ding Q; Department of Laboratory Medicine, and the Keenan Research Centre for Biomedical Science at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Rotondo F; Department of Laboratory Medicine, and the Keenan Research Centre for Biomedical Science at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Evans KR; Ontario Cancer Biomarker Network, MaRS Centre, Toronto, Ontario, Canada.
  • Kupchak P; Ontario Cancer Biomarker Network, MaRS Centre, Toronto, Ontario, Canada.
  • Dharsee M; Ontario Cancer Biomarker Network, MaRS Centre, Toronto, Ontario, Canada.
  • Latif A; Department of Laboratory Medicine, and the Keenan Research Centre for Biomedical Science at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Pasic MD; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Lianidou E; Department of Chemistry, University of Athens, Athens, Greece.
  • Bjarnason GA; Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Center, Toronto, Ontario, Canada. Electronic address: bjarnason@sri.utoronto.ca.
  • Yousef GM; Department of Laboratory Medicine, and the Keenan Research Centre for Biomedical Science at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine and Path
Mol Ther ; 23(11): 1748-1758, 2015 Nov.
Article in En | MEDLINE | ID: mdl-26201448
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrroles / Carcinoma, Renal Cell / Angiogenesis Inhibitors / Vascular Endothelial Growth Factor Receptor-2 / MicroRNAs / Biomarkers, Pharmacological / Indoles / Kidney Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans / Middle aged Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2015 Document type: Article Affiliation country: Canada
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrroles / Carcinoma, Renal Cell / Angiogenesis Inhibitors / Vascular Endothelial Growth Factor Receptor-2 / MicroRNAs / Biomarkers, Pharmacological / Indoles / Kidney Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans / Middle aged Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2015 Document type: Article Affiliation country: Canada